F2RL3 and colorectal cancer: The increase of PAR4 expression in colorectal cancer was consistent with Gratio’s research results [12], in which PAR4 was absent in normal colonic mucosa and epithelial cells, but high in colon adenocarcinoma tissues, and 71% human colorectal cell lines show strong immunostaining of PAR4 [12].